BR9612256A - Linhagens de células cutâneas humanas imortalizadas e meio livre de soro utilizável para sua produção - Google Patents

Linhagens de células cutâneas humanas imortalizadas e meio livre de soro utilizável para sua produção

Info

Publication number
BR9612256A
BR9612256A BR9612256A BR9612256A BR9612256A BR 9612256 A BR9612256 A BR 9612256A BR 9612256 A BR9612256 A BR 9612256A BR 9612256 A BR9612256 A BR 9612256A BR 9612256 A BR9612256 A BR 9612256A
Authority
BR
Brazil
Prior art keywords
cell lines
serum
human skin
production
free medium
Prior art date
Application number
BR9612256A
Other languages
English (en)
Other versions
BR9612256B1 (pt
Inventor
Markus Baur
Catherine Mace
Armand Malmoe
Andrea M A Pfeifer
Marcelle Rignier
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of BR9612256A publication Critical patent/BR9612256A/pt
Publication of BR9612256B1 publication Critical patent/BR9612256B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
    • C12N5/0629—Keratinocytes; Whole skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides, bases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/44—Thiols, e.g. mercaptoethanol
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/46—Amines, e.g. putrescine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/80—Neurotransmitters; Neurohormones
    • C12N2501/81—Adrenaline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI9612256-0A 1995-12-21 1996-12-19 método aperfeiçoado para a imortalização de células cutáneas humanas e meio de cultura. BR9612256B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57648395A 1995-12-21 1995-12-21
PCT/EP1996/005812 WO1997023602A1 (en) 1995-12-21 1996-12-19 Improved immortalized human skin cell lines and novel serum-free medium useful for the production thereof

Publications (2)

Publication Number Publication Date
BR9612256A true BR9612256A (pt) 1999-07-13
BR9612256B1 BR9612256B1 (pt) 2010-08-10

Family

ID=24304605

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9612256-0A BR9612256B1 (pt) 1995-12-21 1996-12-19 método aperfeiçoado para a imortalização de células cutáneas humanas e meio de cultura.

Country Status (23)

Country Link
US (2) US6423540B2 (pt)
EP (2) EP0877797A1 (pt)
JP (1) JP4404965B2 (pt)
KR (1) KR100455006B1 (pt)
CN (1) CN1154717C (pt)
AT (1) ATE199390T1 (pt)
AU (1) AU730222B2 (pt)
BR (1) BR9612256B1 (pt)
CA (1) CA2234118C (pt)
CZ (1) CZ297289B6 (pt)
DE (1) DE69611894T2 (pt)
DK (1) DK0780469T3 (pt)
ES (1) ES2155166T3 (pt)
GR (1) GR3035719T3 (pt)
HU (1) HU226195B1 (pt)
IL (1) IL124191A (pt)
NO (1) NO326190B1 (pt)
NZ (1) NZ325814A (pt)
PL (1) PL195108B1 (pt)
PT (1) PT780469E (pt)
RU (1) RU2215030C2 (pt)
SK (1) SK283314B6 (pt)
WO (1) WO1997023602A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ325814A (en) * 1995-12-21 2000-10-27 Nestle Sa Process for immortalizing human skin cell lines and a serum-free medium
WO1999054435A2 (fr) * 1998-04-17 1999-10-28 Societe Des Produits Nestle Lignee de cellules immortalisees derivees de tissus cutanes humains normaux
US6964869B2 (en) 1998-07-13 2005-11-15 Wisconsin Alumni Research Foundation Method and composition for skin grafts
CN1087778C (zh) * 1999-03-02 2002-07-17 华东理工大学 杂交瘤细胞无血清培养基
DE19912798C1 (de) 1999-03-10 2000-02-17 Andreas Jordan Verfahren zur Kultivierung von Krebszellen aus Humangewebe und Vorrichtung zur Aufbereitung von Gewebeproben
AUPR298901A0 (en) 2001-02-07 2001-03-08 McComb Foundation, Inc., The Cell suspension preparation technique and device
EP1390754B1 (en) * 2001-04-24 2007-08-01 Wisconsin Alumni Research Foundation Method and composition for skin grafts
WO2002091999A2 (en) 2001-05-09 2002-11-21 Geron Corporation Treatment for wounds
US20030022369A1 (en) * 2001-05-18 2003-01-30 Helen Fillmore Differentiation of specialized dermal and epidermal cells into neuronal cells
CA2452660A1 (en) * 2001-07-06 2003-01-16 Lipomics Technologies, Inc. Generating, viewing, interpreting, and utilizing a quantitative database of metabolites
GB0208041D0 (en) 2002-04-08 2002-05-22 Lonza Biologics Plc Method of culturing animal cells
US20050025737A1 (en) * 2003-07-30 2005-02-03 Sebagh Jean Louis Compositions containing melon extracts
KR20060076781A (ko) * 2003-09-18 2006-07-04 레이븐 바이오테크놀로지스, 인코퍼레이티드 세포 배양 배지
WO2005071065A1 (en) * 2004-01-26 2005-08-04 Cognis France S.A.S Method for studying functional interactions between sensory neurons and keratinocytes or melanocytes
WO2006101834A1 (en) 2005-03-17 2006-09-28 Stratatech Corporation Skin substitutes with improved purity
EP1818392B1 (en) * 2006-02-14 2010-08-25 Genetix Limited Cell culture medium
US8637310B2 (en) 2008-12-05 2014-01-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of a rock inhibitor to sustain primary human keratinocytes in a proliferative state
WO2010134619A1 (ja) * 2009-05-18 2010-11-25 国立大学法人東北大学 人工多能性幹細胞からの上皮系前駆細胞・幹細胞群及び角膜上皮細胞群の分化誘導方法
KR101768632B1 (ko) * 2011-05-18 2017-08-17 (주)아모레퍼시픽 칼슘 펄스를 통한 배양상피세포층의 분리방법
CA2841822C (en) * 2011-07-12 2016-08-16 Foodchek Systems Inc. Culture medium, method for culturing salmonella and e. coli and method for detecting salmonella and e. coli
WO2013129885A1 (ko) * 2012-02-28 2013-09-06 건국대학교 산학협력단 세포 배양액
CN105308175B (zh) 2013-03-11 2018-09-21 日本化学研究株式会社 人角膜上皮片的制造法
AU2013205148B2 (en) 2013-03-14 2014-10-30 AVITA Medical Americas, LLC Systems and methods for tissue processing and preparation of cell suspension therefrom
KR20160065038A (ko) 2014-11-28 2016-06-08 (주)아모레퍼시픽 멜라닌 세포주 계대배양계 및 이를 이용한 노화 수준 판단, 미용 정보 제공, 또는 스크리닝 방법
WO2016122438A1 (en) * 2015-01-26 2016-08-04 Halliburton Energy Services, Inc. Rotating superhard cutting element
CN105238739A (zh) * 2015-11-11 2016-01-13 朱宁文 临床治疗级细胞治疗用黑色素细胞(melanocytes)规模化制备人类细胞外基质筛选培养方法
CN106520674A (zh) * 2016-12-24 2017-03-22 严志海 一种用于表皮黑素细胞体外培养的无血清培养基
CN107115219A (zh) * 2017-05-12 2017-09-01 青岛赛欧凯普图乐生物医药有限公司 一种纤维芽母细胞活化液面膜配方
CN114058565A (zh) * 2020-07-31 2022-02-18 上海尚瑞生物医药科技有限公司 一种无血清的黑素母细胞培养液及其培养方法
KR102583179B1 (ko) * 2020-11-27 2023-09-26 (주)엑셀세라퓨틱스 칼슘, 상피세포성장인자 및 알부민을 포함하는 각질형성세포 수립 또는 배양용 배지 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940666A (en) * 1983-07-15 1990-07-10 University Patents, Inc. Process and defined medium for growth of human epidermal keratinocyte cells
US4885238A (en) 1987-10-30 1989-12-05 The United States Of America As Represented By The Department Of Health And Human Services Immortalized human bronchial epitherial mesothelial cell lines
US5292655A (en) 1990-01-29 1994-03-08 Wille Jr John J Method for the formation of a histologically-complete skin substitute
US5376542A (en) 1992-04-27 1994-12-27 Georgetown University Method for producing immortalized cell lines using human papilluma virus genes
EP0937460A3 (en) * 1994-04-12 2000-04-05 Adolor Corporation Use of an antidiarrheal for the manufacture of a medicament for the treatment of inflammatory conditions
DE19617261A1 (de) 1995-04-21 1996-11-28 Naeher Helmut Dr Med Priv Doz Hautverträglichkeitstest
NZ325814A (en) * 1995-12-21 2000-10-27 Nestle Sa Process for immortalizing human skin cell lines and a serum-free medium

Also Published As

Publication number Publication date
BR9612256B1 (pt) 2010-08-10
EP0877797A1 (en) 1998-11-18
IL124191A (en) 2004-06-01
CA2234118A1 (en) 1997-07-03
KR100455006B1 (ko) 2005-01-13
NO982810L (no) 1998-08-21
CZ194598A3 (cs) 1998-11-11
PL327320A1 (en) 1998-12-07
ATE199390T1 (de) 2001-03-15
US20020012993A1 (en) 2002-01-31
HUP9903742A3 (en) 2000-10-30
CN1154717C (zh) 2004-06-23
HUP9903742A2 (hu) 2000-03-28
DE69611894D1 (de) 2001-04-05
EP0780469B1 (fr) 2001-02-28
AU730222B2 (en) 2001-03-01
DE69611894T2 (de) 2001-09-13
CN1205737A (zh) 1999-01-20
EP0780469A1 (fr) 1997-06-25
SK283314B6 (sk) 2003-05-02
RU2215030C2 (ru) 2003-10-27
CA2234118C (en) 2009-04-07
AU1305497A (en) 1997-07-17
GR3035719T3 (en) 2001-07-31
HU226195B1 (hu) 2008-06-30
NZ325814A (en) 2000-10-27
KR19990071817A (ko) 1999-09-27
SK83598A3 (en) 1999-01-11
US6949381B2 (en) 2005-09-27
JP4404965B2 (ja) 2010-01-27
PL195108B1 (pl) 2007-08-31
WO1997023602A1 (en) 1997-07-03
NO326190B1 (no) 2008-10-13
DK0780469T3 (da) 2001-03-26
JP2000506374A (ja) 2000-05-30
US6423540B2 (en) 2002-07-23
ES2155166T3 (es) 2001-05-01
PT780469E (pt) 2001-06-29
NO982810D0 (no) 1998-06-18
CZ297289B6 (cs) 2006-10-11
US20020042129A1 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
BR9612256A (pt) Linhagens de células cutâneas humanas imortalizadas e meio livre de soro utilizável para sua produção
EP1538202A3 (en) Production of human alpha-galactosidase A
PL323737A1 (en) Method of controlling sialination of proteins produced by cultures of mammals tissue cells
CA2157391A1 (en) Human liver epithelial cell lines
NO992704L (no) Serum-fritt celledyrkningsmedium
DE69638059D1 (de) Kulturmedium für mikroorganismen
PT971679E (pt) Metodo de reproducao de cabelo
DE69611778T2 (de) Separator für feststoffpolyelektrolytbrennstoffzellen und dessen herstellung
EP0682107A3 (en) Process for the long-term culture of cells of the dermal papilla.
HUP9802640A3 (en) Cell culture method organ tissue implantum from cell population which was made by this method
HUP0101913A2 (hu) Normál humán bőrszövetekből származó, immortalizált sejtvonal
GB9825096D0 (en) Cells,culture methods and their uses
TW200718944A (en) Screening methods for compounds that affect melanogenesis
CY1106955T1 (el) Μεθοδος για συνθεση για δερματικα μοσχευματα
AU7739296A (en) Novel method of culturing human epithelial cells for the identification of cancer therapeutics and diagnostics
DE69606012T2 (de) Elektrode für Membran-Elektrolysezellen
DK0858502T3 (da) Normale, neurale epitelprecursorceller
WO1997016453A3 (en) Pancratistatins and processes for their production
MX9709783A (es) Inmortalizacion y desinmortalizacion de celulas.

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/08/2010, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)
B15K Others concerning applications: alteration of classification

Ipc: C12N 5/071 (2010.01), A61K 35/12 (2015.0